This year’s London Life Sciences Week was another fantastic opportunity to connect with innovators, investors, and industry leaders shaping the future of healthcare and biotech. The week commenced with the LSX Investival Showcase, proudly sponsored by DFIN for the seventh consecutive year—a milestone that reflects our deep commitment to the life sciences ecosystem.

On 28 October 2025, DFIN proudly partnered with the London Stock Exchange Group (LSEG) in Singapore to support the Asia Pacific Capital Markets Forum. This influential event brought together leading voices from Ashurst, Peel Hunt, and DFIN, alongside special guest Eben Upton, CEO of Raspberry Pi, to explore why London continues to be a compelling venue for Asia Pacific companies seeking global capital access.

Featured speakers:

An IPO is never just a financing exercise—it’s a rigorous compliance and stakeholder management challenge. From due diligence and prospectus drafting to the execution of the listing process, every step directly impacts a company’s reputation and its future in the capital markets.

For advisors, the complexity lies not only in meeting regulatory requirements but also in orchestrating efficient collaboration across multiple stakeholders, geographies, and time zones.

Taking a company public is a significant milestone that can unlock new opportunities for growth, visibility, and investor confidence. While there are several ways to enter the public market, this article explores direct listings vs IPOs in detail, helping companies assess which approach best aligns with their financial goals, market conditions, and long-term strategy.

"Q1 started strong with fourteen $50M+ offerings in the initial six weeks. However, escalating concerns over tariffs, recession fears, sticky inflation, and budget talks led to market volatility, delaying hopes for a stabilized IPO market. Despite these challenges, Q1 concluded with CoreWeave entering the public market, and we are optimistic that Q2 will bring the clarity and stability needed for a normalized IPO market."  Craig Clay, President of Global Capital Markets, DFIN

The initial public offering (IPO) process includes a long list of responsibilities, and filing several disclosure forms is among the most important. Determining which documents to provide and assembling the information can take a significant amount of time. Among the disclosure forms that corporations must file is SEC Form 424. This form provides information about the offering for investors to review and use to decide whether to buy shares.

Dealmakers entered 2025 with cautious optimism, hoping that the tailwinds from late 2024 would carry through. The economic climate shifted toward volatility, with tariffs, policy shakeups, and global market swings dominating the headlines of the new year. However, as market conditions stabilized across May and June, we’ve seen encouraging trends in market activity kicking off the beginning of Q3.